2m 2m 2m 2m 2m 2m 2m
Milestone Scient (MLSS)
NYSE
$0.30-$0.03 (-8.51%)
Price as of Jun 23, 2026 8:00 PM EDT- $29.1MMarket Cap
- -58.69%1-Year Change
- Medical Instruments & SuppliesIndustry
Milestone Scient (MLSS)
$0.30-$0.03 (-8.51%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 60,265 -51.99% | 125,527 +129.87% | 54,607 +433.78% | |
Cost of Revenue | N/A N/A | 2.2M -27.66% | 3.0M -22.29% | 3.9M -2.20% | |
Gross Profit | 0 -100.00% | 6.4M -5.27% | 6.8M +38.60% | 4.9M -22.36% | |
Sales and Marketing Expense | 11.6M -5.85% | 12.3M -6.40% | 13.1M +4.97% | 12.5M -1.76% | |
Research and Development Expense | -449,469 -47.66% | -858,767 +22.44% | -701,378 -39.02% | -1.2M +30.97% | |
Depreciation and Amortization Expense | 69,341 +129.36% | 30,232 -38.70% | 49,320 -0.69% | 49,663 -3.81% | |
Total Operating Expenses | 12.1M -8.24% | 13.2M -5.09% | 13.9M +1.24% | 13.7M +0.28% | |
Operating Profit | -5.7M -15.69% | -6.8M -4.92% | -7.1M -19.50% | -8.8M +19.64% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -25,599 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -25,599 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | -25,599 -142.48% | 60,265 -51.99% | 125,527 +129.87% | 54,607 +433.78% | |
Income before Taxes | -5.7M +21.40% | -4.7M -32.48% | -7.0M -20.43% | -8.8M +23.24% | |
Income Taxes | N/A N/A | N/A N/A | 0 N/A | 0 -100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | -4.7M -31.97% | -6.9M -20.41% | -8.7M +27.69% | |
Net Income from Continuing Operations Applicable to Common | -5.7M +21.40% | -4.7M -32.48% | -7.0M -19.82% | -8.7M +27.69% | |
Basic EPS and Net Income | -0.07 +16.67% | -0.06 -40.00% | -0.10 -16.67% | -0.12 +20.00% | |
Diluted EPS and Net Income | -0.07 +16.67% | -0.06 -40.00% | -0.10 -16.67% | -0.12 +20.00% | |
Basic Weighted Average Shares | 82.1M +2.85% | 79.8M +9.64% | 72.8M +3.07% | 70.6M +2.58% | |
Diluted Weighted Average Shares | 82.1M +2.85% | 79.8M +9.64% | 72.8M +3.07% | 70.6M +2.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.1M -65.85% | 3.3M +9.41% | 3.0M -65.83% | 8.7M -40.97% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 3.0M -65.79% | 8.7M -37.41% | |
Cash and Cash Equivalents and Short-Term Investments | 1.1M -65.85% | 3.3M -45.28% | 6.0M -65.81% | 17.4M -39.24% | |
Total Current Assets | 7.5M -19.48% | 9.3M -13.97% | 10.8M -16.78% | 13.0M -31.50% | |
Accumulated Depreciation | 932,970 +0.77% | 925,830 +0.79% | 918,610 +1.44% | 905,611 +1.59% | |
Property and Plant and Equipment and Net | 19,193 +48.54% | 12,921 +28.90% | 10,024 -44.76% | 18,146 -23.48% | |
Total Long-Term Assets | 24,150 0.00% | 24,150 0.00% | 24,150 0.00% | 24,150 0.00% | |
Total Assets | 7.8M -20.32% | 9.8M -13.85% | 11.4M -17.01% | 13.7M -30.83% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 819,000 N/A | |
Total Current Liabilities | 4.1M +10.34% | 3.7M +21.69% | 3.1M -6.76% | 3.3M +6.53% | |
Total Long-Term Debt | 800,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 35,208 -78.74% | 165,573 -41.26% | 281,853 -26.84% | 385,279 -19.23% | |
Total Liabilities | 5.0M +25.97% | 4.0M +18.02% | 3.4M -9.11% | 3.7M +2.82% | |
Retained Earnings | -133.8M +4.47% | -128.1M +3.82% | -123.3M +5.95% | -116.4M +8.09% | |
Total Stockholders Equity | N/A N/A | 5.8M -27.21% | 8.0M -21.64% | 10.2M -37.53% | |
Total Shares Outstanding | 80.5M +3.13% | 78.0M +2.86% | 75.8M +9.49% | 69.3M +1.69% | |
Cash Flow | |||||
Cash from Operating Activities | -2.9M -0.11% | -2.9M -45.18% | -5.3M -11.70% | -6.0M +50.14% | |
Capital Expenditures | 15,124 N/A | N/A N/A | N/A N/A | 8,527 -43.86% | |
Cash from Investing Activities | -15,124 -100.51% | 3.0M +199.81% | -3.0M +34,756.01% | -8,527 -43.86% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 786,335 +236.37% | 233,771 -90.87% | 2.6M +30,071.15% | -8,544 -100.19% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | -3,542.81% +52.86% | -2,317.67% -67.13% | -7,051.27% -128.77% | |
Operating Margin | N/A N/A | -11,212.07% +98.05% | -5,661.31% -64.98% | -16,165.46% -135.84% | |
Return on Assets | N/A N/A | -44.53% -19.42% | -55.27% +6.37% | -51.96% +50.05% | |
Return on Equity | N/A N/A | -68.09% -10.39% | -75.98% +16.05% | -65.48% +56.38% | |
Revenue Growth | N/A N/A | -51.99% -140.03% | 129.87% -70.06% | 433.78% +226.15% | |
Current Ratio | 1.81 -27.02% | 2.48 -29.30% | 3.51 -10.75% | 3.93 -35.70% | |
Cash Ratio | 0.27 -69.05% | 0.87 -10.08% | 0.97 -63.36% | 2.64 -44.59% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow